Individual Factors of CBT Underlying Success
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT06678295
- Status
- Recruiting
Conditions
- Body Dysmorphic Disorder
- Social Anxiety Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- Cognitive Behavioral Therapy — BEHAVIORALTwelve weekly sessions of individual cognitive behavioral therapy
Study Details
The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.
Key Dates
- Start date
- Oct 15, 2024
- Status verified
- Feb 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Cognitive behavioral therapyTwelve weekly sessions of individual cognitive behavioral therapy
Primary Outcome Measure
Trait SFA assessed by the Public Self-Consciousness Scale- Revised (SCS-R) [ Time Frame: Across the span of 3 1/2 months: Baseline (T-2weeks), Repeat Baseline (T0), Week 3, Week 6, Week 9, Post-treatment ]
Central Contacts
- Angela Fang, PhD(206) 616-5783
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Washington | Seattle | Washington | 98105 |
Find similar trials in Seattle, WA
By research site
Related Studies
- Computer - Based Treatment for Social Anxiety DisorderRecruiting · New York State Psychiatric Institute · New York, New York
- Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for ComorbidityRecruiting · University of Minnesota · Minneapolis, Minnesota
- Respiratory Training in the Treatment of Transdiagnostic Pathological AnxietyRecruiting · University of Texas at Austin · Austin, Texas
- CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based TherapyRecruiting · Jasper A. Smits · Boston, Massachusetts